If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be ...

AI-assisted drug discovery isn’t just science fiction anymore, especially as biotechnology and biopharma firms embrace the AI ...

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

At least nine engineers, including two co-founders, have announced their exits from xAI in the past week, fueling online speculation and raising questions about stability at Musk’s AI company amid ...

AI co-founders Tony Wu and Jimmy Ba announced on X that they have quit the AI start-up, adding their name in the list of ...

Cathie Wood’s ARK Invest continued trimming its exposure to Coinbase on Friday, selling roughly $22 million worth of shares across three exchange-traded ...

Cathie Wood's ARK bought $9.67M in Roblox stock Feb 9 while selling PagerDuty for fifth day. Full breakdown of ARK Invest ...

Future AI-guided genomic analysis offers the potential to further optimize gene constructs, expression profiles, and performance traits, accelerating the development of next-generation materials.

The art and digital culture festival reminded us that networked, relational structures have a robust tradition outside big ...

Within days of release, Clawdbot became a sensation, delivering both the promise of productivity and a security nightmare, while giving a glimpse of our agent-run future writes Satyen K. Bordoloi ...

ARK Invest sold $22M in Coinbase shares and added Bullish exposure, signaling a quick strategy shift as crypto stocks rallied ...

Ark Invest bought additional Bullish shares, rebalanced ETFs, and reduced Coinbase holdings significantly.